A Novel Combination of Blood Biomarkers and Clinical Stroke Scales Facilitates Detection of Large Vessel Occlusion Ischemic Strokes
DOI: 10.3390/diagnostics11071137

Our products use biological and lifestyle parameters to control the physical state and well-being of the body. We use our own patented technology.
By relying on epigenetics, our goal is to reveal in real time the impact that the environment around us has on the organism. We also use this information to improve health, prevent diseases and extend life expectancy.
Inspiring young generations to adopt a healthier lifestyle is vital for the overall well-being of the population and for promoting healthy aging. The improvement of physical form, the increase of mental resilience and the protection against developing age-related diseases are some of its benefits. Educating young people about the importance of healthy habits from an early age will equip them with informed decisions and create a healthier future for our society.
Trust is built with evidence. That’s why we share published research and clearly distinguish between peer‑reviewed articles and preprints.
DOI: 10.3390/diagnostics11071137
DOI: 10.20944/preprints202601.1738.v1
Not peer‑reviewed (preprint).
Note: A preprint is a public manuscript that has not yet undergone peer review. We include it as part of our commitment to scientific transparency.





















Institutional recognition of our innovation project
Startquake S.L.’s project to commercialize its ProAge and ActiveAge products has been subsidized under the Technology-Based Companies Grant Phase II of the Principality of Asturias. The project has been co-financed by the Government of the Principality of Asturias through the SEKUENS Agency and the Science, Technology and Innovation Plan (PCTI) 2018-2022, and by the European Union through ERDF.


The grant supports the hiring of graduates to carry out R&D activities. The project covered by the grant is titled “Testing and validation of ‘in silico’ biomarkers”. It is co-financed by the Government of the Principality of Asturias through the Foundation for the Promotion of Applied Scientific Research and Technology in Asturias (FICYT) and by the European Union through the European Regional Development Fund (ERDF).
Startquake S.L.’s project to commercialize its ProAge and ActiveAge products has been subsidized under the Technology-Based Companies Grant Phase II of the Principality of Asturias. The project has been co-financed by the Government of the Principality of Asturias through the SEKUENS Agency and the Science, Technology and Innovation Plan (PCTI) 2018-2022, and by the European Union through ERDF.
Startquake S.L., together with a consortium of companies, has been a beneficiary of this grant under the “TE CUIDAS” programme. The project develops technologies aimed at supporting healthy, autonomous longevity for vulnerable groups at risk of social exclusion. The grant was funded by the Regional Ministry of Science, Innovation and Universities under the Scientific Missions programme of the Principality of Asturias 2022.
Startquake S.L.’s project “Development of bespoke tests for Startquake analysis” has been subsidized under the “Activa Startups” grant within the Recovery, Transformation and Resilience Plan for SMEs in the Autonomous Community of Asturias (ATS_PYME_007). It is funded by the European Union – Next Generation EU, and by the Ministry of Industry, Commerce and Tourism.
The reference for the grant received by Startquake S.L. is DIN2020-011530; it was funded by the Ministry of Science and Innovation (MCIN) and the State Research Agency (AEI), agency DOI 10.13039/501100011033. This grant falls under support for doctoral training in companies through the “Torres Quevedo” initiative.
Startquake S.L. has been funded through the project “Measuring ageing with wearable technology”, awarded by the Chambers of Commerce of Asturias as part of the Recovery, Transformation and Resilience Plan – financed by the European Union – NextGenerationEU.